Regulatory policy as innovation: Constructing rules of engagement for a technological zone of tissue engineering in the European Union

This paper addresses the question of the part that regulation plays in processes of innovation in sectors of technology. The politico-economic phenomenon of 'Europe' is partly constituted by regulatory regime-building, and new technologies are one of the major sites of regime-building. A constructionist social theory perspective shows that study of the conflictual processes of regulatory policymaking affords insights into the formation of the rules of engagement that constitute technology domains. Adopting the concept of emergent 'technological zone' in preference to industrial 'sector' or technoscientific network, the paper presents, using empirical research, a detailed account of the case of the debate and development of regulatory policy for therapeutic tissue engineering in the European Union's policy institutions and stakeholder networks. It describes how the jurisdiction of an emergent zone has been formed through such negotiations, providing a counter-example to the common view that regulation 'lags behind' innovation. The analysis takes account particularly of the part played by the malleability of the definition of the material technology itself in such constructive governance processes, and it also suggests various consequences for the array of producers of the technology, for market structuring and for the innovation pathways taken by tissue engineering technology. Concluding, the paper argues that there is conceptual advance to be made by bringing together constructionist social theory with innovation studies approaches that highlight the part played by non-firm, public institutions in shaping innovation ecologies.

[1]  L. Leydesdorff,et al.  The dynamics of innovation: from National Systems and , 2000 .

[2]  Sibylle Gaisser,et al.  Human Tissue Engineered Products - Today's Markets and Future Prospects , 2003 .

[3]  L. Hogle Claims and disclaimers: Whose expertise counts? , 2002, Medical anthropology.

[4]  Julie Kent,et al.  Human tissue engineered products—drugs or devices? , 2003, BMJ : British Medical Journal.

[5]  M. Callon The Sociology of an Actor-Network: The Case of the Electric Vehicle , 1986 .

[6]  J. Abraham,et al.  Progress, Innovation and Regulatory Science in Drug Development , 2002, Social studies of science.

[7]  Rom Harré,et al.  Material Objects in Social Worlds , 2002 .

[8]  Alex Faulkner,et al.  Medical Technology into Healthcare and Society: A Sociology of Devices, Innovation and Governance , 2008 .

[9]  A. Faulkner,et al.  Tissue-Engineered Technologies: Scientific Biomedicine, Frames of Risk and Regulatory Regime-Building in Europe , 2008 .

[10]  Robert Bud Resistance to new technology: In the engine of industry: regulators of biotechnology, 1970–86 , 1995 .

[11]  Stuart S. Blume,et al.  Insight and Industry: On the dynamics of technological change in Medicine Cambridge , 1991 .

[12]  Jerry Ravetz Science and Governance in the European Union. A Contribution to the Debate. , 2000 .

[13]  Martin Bauer Resistance to New Technology: Nuclear Power, Information Technology, Biotechnology , 1995 .

[14]  M. Callon Europe wrestling with technology , 2004 .

[15]  D. Vogel The new politics of risk regulation in Europe , 2001 .

[16]  F. Malerba NEW CHALLENGES FOR SECTORAL SYSTEMS OF INNOVATION IN EUROPE , 2002 .

[17]  Julie Kent,et al.  Purity and the dangers of regenerative medicine: Regulatory innovation of human tissue-engineered technology , 2006, Social Science & Medicine.

[18]  C. Waldby Stem Cells, Tissue Cultures and the Production of Biovalue , 2002 .

[19]  A. Clarke,et al.  Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine , 2003, American Sociological Review.

[20]  R. Rhodes Understanding governance : policy networks, governance, reflexivity and accountability , 1997 .

[21]  A. Barry Political Machines: Governing a Technological Society , 2001 .

[22]  Gerard Delanty,et al.  Book Review: Rethinking Europe: Social Theory and the Implications of Europeanization , 2006 .

[23]  M. Steffen Health governance in Europe : issues, challenges and theories , 2005 .

[24]  Les Levidow,et al.  Recasting “Substantial Equivalence”:Transatlantic Governance of GM Food , 2007 .

[25]  L. Sharp Bodies, boundaries, and territorial disputes: Investigating the Murky Realm of scientific authority , 2002, Medical anthropology.

[26]  E. Vos Institutional frameworks of community health and safety legislation : committees, agencies and private bodies , 1999 .

[27]  E. Millstone Science, risk and governance: Radical rhetorics and the realities of reform in food safety governance , 2009 .

[28]  P. Glasner Banking on Immortality? Exploring the Stem Cell Supply Chain from Embryo to Therapeutic Application , 2005 .

[29]  M. Callon,et al.  Mapping the dynamics of science and technology : sociology of science in the real world , 1988 .

[30]  M. Gibbons,et al.  Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty , 2003 .

[31]  P. Conrad The Shifting Engines of Medicalization∗ , 2005 .

[32]  W. Powell,et al.  The New Institutionalism in Organizational Analysis , 1993 .

[33]  Julie Kent,et al.  Culturing Cells, Reproducing and Regulating the Self , 2006 .

[34]  John Abraham,et al.  Interpellative Sociology of Pharmaceuticals: Problems and Challenges for Innovation and Regulation in the 21st Century , 2007, Technol. Anal. Strateg. Manag..

[35]  A. Faulkner,et al.  Towards governance of human tissue engineered technologies in Europe: Framing the case for a new regulatory regime , 2006 .

[36]  John Metcalfe,et al.  Emergent innovation systems and the delivery of clinical services: The case of intra-ocular lenses , 2005 .

[37]  Mike Michael,et al.  Regulating Hybrids: ‘Making a Mess’ and ‘Cleaning Up’ in Tissue Engineering and Transpecies Transplantation , 2006, Social theory & health : STH.

[38]  J. Abraham,et al.  Regulating Medicines in Europe: Competition, Expertise and Public Health , 2000, BMJ : British Medical Journal.

[39]  Paul Martin,et al.  The Drugs Don't Work , 2003, Social studies of science.

[40]  H. Klein,et al.  The Social Construction of Technology: Structural Considerations , 2002 .